Skip to content

Comparison of the effects of ciprofol and ciprofol combined with remimazolam in painless gastroenteroscopy procedures

Comparison of the effects of ciprofol and ciprofol combined with remimazolam in painless gastroenteroscopy procedures

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092506
Enrollment
Unknown
Registered
2024-11-18
Start date
2024-11-18
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

group RC:Propofol combined with Remimazolam

Sponsors

The Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1: Patients aged 18-85 years undergoing painless gastroscopy or painless gastroenteroscopy 2: American Society of Anesthesiologists (ASA) classification of Class I-III 3: MET=3 4: 18kg/m2<BMI<28kg/m2 4: 18kg/m2<BMI<28kg/m2

Exclusion criteria

Exclusion criteria: ASA IV and above patients Patients with severe loose teeth, extremely severe obstructive ventilation dysfunction, anemia or thrombocytopenia, Patients with pulse oximetry (SpO2)<94% before anesthesia, severe liver and kidney dysfunction, pregnant or lactating patients; Patients are allergic or have contraindications to dinitrogen drugs, cyclosporine, lidocaine, benzodiazepines Patients have participated in clinical trials of other drugs in the past 3 months, and have undergone painless colonoscopy alone are considered unsuitable by the respondents.

Design outcomes

Primary

MeasureTime frame
Frequency of hypoxemia during painless gastroenteroscopy;

Secondary

MeasureTime frame
Minimum oxygen saturation during painless gastroenteroscopy;awake time;comparisons of vital signs during procedure;Onset of anesthesia;Number of occurrences of hypoxemia;

Countries

China

Contacts

Public ContactHaiding Zou

The Second Xiangya Hospital, Central South University

zhd2019@csu.edu.cn+86 150 8496 8406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026